FNA News and Press, Paragon 28 Inc. From 04/04/24

2024-04-04 17:15:03 ET Piper Sandler analyst issues BUY recommendation for FNA on April 4, 2024 04:00PM ET. The previous analyst recommendation was Buy. FNA was trading at $10.2 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current anal...

2024-04-04 10:48:26 ET More on Paragon 28 Paragon 28, Inc. 2023 Q4 - Results - Earnings Call Presentation Needham sees orthopedics market slowing; favors Enovis, Paragon 28 Seeking Alpha’s Quant Rating on Paragon 28 Read the full article on Seeking A...

Stephen Deitsch resigns from his position as Chief Financial Officer to pursue another opportunity; Kristina Wright appointed interim Chief Financial Officer Preliminary, unaudited first quarter 2024 net revenue expected to be in a range of $60.8 to $61.1 million, representing 16.8% to 17.4% ...

2024-03-31 19:46:03 ET More on Alphatec, Enovis Corporation, etc. IHI: Technological Advances Will Continue Carrying This High-Performing Medical ETF Alphatec Holdings, Inc. (ATEC) Q4 2023 Earnings Call Transcript Enovis Corporation (ENOV) Q4 2023 Earnings Call Trans...

Paragon 28, Inc. (NYSE: FNA), is pleased to announce the launch of the Grappler ® R3INFORCE™ Extraosseous Repair System designed to restore stability to the anterior and posterior ligaments surrounding the ankle during fibula fracture repairs and high ankle sprains. This press...

2024-03-12 14:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “Company”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today reported financial results for the quarter and year ended December 31, 2023 and provided 2024 Net Revenue guida...

Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...

2024-02-25 18:50:34 ET More on Enovis Corporation, Paragon 28, etc. Enovis Corporation (ENOV) Q4 2023 Earnings Call Transcript Enovis Corporation Non-GAAP EPS of $0.79 beats by $0.05, revenue of $455.02M beats by $9.63M Enovis Corporation Q4 2023 Earnings Preview ...

Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO and Steve Deitsch, CFO will participate in a fireside chat at the CG 2024 Musculoskeletal Conference on Monday, Februar...